novel treatment approaches in bpdcn: the promise of cd123-targeting allogeneic car-t cells
Published 1 year ago • 88 plays • Length 4:41Download video MP4
Download video MP3
Similar videos
-
1:23
the promise of cd123-targeted therapy in bpdcn
-
33:25
novel therapeutic approaches in bpdcn : targeting cd123 and beyond
-
2:20
design of a phase i trial of allogeneic anti-cd123 car t-cells in r/r aml
-
0:41
cd123 car-t therapy for the treatment of aml
-
3:45
imgn632: a novel cd123 adc for r/r aml and bpdcn
-
10:41
blastic plasmacytoid dendritic cell neoplasm ( learn in 10 minutes)
-
5:38
novel agents for bpdcn management
-
0:41
access to novel breast cancer therapies
-
2:09
major breakthroughs in bpdcn treatment
-
1:34
cctx-001: a novel car-t therapy for aml
-
2:37
recent advances in the treatment of bpdcn & the long-term benefits of tagraxofusp
-
2:37
the problem of treating aml with cd123-targeting drugs
-
2:13
cd123 targeted therapies for hematologic malignancies
-
1:36
imgn632: a novel cd123-targeted antibody-drug conjugate for r/r bpdcn
-
2:12
novel agents of interest for the treatment of bpdcn
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
4:17
novel car t-cell therapies for hematological malignancies: exploring new targets
-
1:08
tagraxofusp: a breakthrough therapy in bpdcn
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:10
cb011: a novel genome-engineered bcma-specific car-t cell therapy
-
2:16
the sequencing of novel therapies in myeloma (car-t, bispecifics, antibody-drug conjugates)
-
1:10
cell expansion and vector design in novel t-cell therapies